The report is titled as ‘Intrauterine Devices Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the intrauterine devices market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The intrauterine devices market is expected to grow at a significant rate in the near future.
The global intrauterine devices market in 2020 is estimated for more than US$ 4.1 Bn and expected to reach a value of US$ 5.9 Bn by 2028 with a significant CAGR of 4.5%.
Intrauterine Devices Market Definition
Intrauterine devices or IUDs are contraceptive medical devices that are used to prevent pregnancy over a period of time. Intrauterine devices are intended for birth control or family planning and prevent unwanted pregnancies. Intrauterine devices act by long-acting reversible contraception that is proven to be 99% effective and safe. There is a number of intrauterine device products in the pipeline which are expected to be launched in the market during the forecast period. However, the availability of a limited number of approved devices limits the widespread use of these devices across the globe. Some of the examples of approved IUDs in the U.S. include Mirena, Jaydess, Kyleena, Liletta, Skyla, etc.
Intrauterine Devices Market Dynamics
Intrauterine devices are quickly gaining attention due to the growing incidence of unintended pregnancies and sexually transmitted diseases it helps to control huge healthcare expenditure on abortions and other health complications of STDs. According to the World Health Organization (WHO) approximately 60% 0f pregnancies in the U.S. are unintended and mistimed. Governments of developed and developing countries are also taking measures to promote the use of intrauterine devices which is expected to drive the growth of the global intrauterine devices market. However, unawareness of the function of intrauterine devices in developing and underdeveloped countries is the factor restraining the growth of the global market.
Intrauterine Devices Market Key Players
The global intrauterine devices market is highly consolidated and is mainly dominated by Pfizer Inc., Agile Therapeutics, Allergan Inc., Bayer AG, Teva Pharmaceutical Company Limited, etc.
Intrauterine Devices Market Segmentation
The global intrauterine devices market is segmented on the basis of product type, distribution channel, and region. On the basis of devices, the global intrauterine devices market can be segmented into copper devices (inert IUDs) and hormonal devices. On the basis of distribution channels, the global intrauterine devices market can be segmented into hospitals, ambulatory surgical centers, obstructive and gynecology clinics, government and non-profit organizations (e.g. WHO), etc.
The global intrauterine devices market is expected to increase at a significant CAGR over the forecast period owing number of new FDA approval and growing penetration of cardiac ablation procedures in the U.S. and other matured markets.
On the basis of region, the global intrauterine devices market is segmented into six regions namely North America, Latin America, Asia Pacific, Europe, Middle East, and Africa. North America intrauterine devices market is expected to be the most dominating market throughout the forecast period due to new product launches.
MMC Overview on Intrauterine Devices Market Report
The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.
A research report on the Intrauterine Devices market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.
Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.
Factors that are benchmarked while estimating the market
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
• New product designs and launches
• Current product compliance
• Reimbursement
• Concerns for use of Intrauterine Devices
• Advantage of Intrauterine Devices
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.
1. Global Intrauterine Devices Report Overview
1.1. Introduction
1.2. Report Description
1.3. Methodology
2. Global Intrauterine Devices Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Executive Summary
2.3. Global Intrauterine Devices Snapshot
2.4. Global Intrauterine Devices Size and Forecast, 2020–2028
2.4.1. Introduction
2.4.2. Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)
2.5. Global Intrauterine Devices Dynamics
2.5.1. Drivers
2.5.2. Restraints
2.5.3. Opportunity
2.5.4. Trends
2.6. Key Regulations
2.7. Porter’s Five Forces Model
3. Global Intrauterine Devices, By Devices
3.1. Introduction
3.1.1. Annual Growth Rate Comparison, By Devices
3.1.2. BPS Analysis, By Devices
3.2. Market Revenue (US$Mn) and Volume (Units) Forecast, By Devices
3.2.1. Copper Devices (Inert Iuds)
3.2.2. Hormonal Devices
3.3. Global Intrauterine Devices Attractiveness Index, By Devices
4. Global Intrauterine Devices, By Distribution Channel
4.1. Introduction
4.1.1. Annual Growth Rate Comparison, By Distribution Channel
4.1.2. BPS Analysis, By Distribution Channel
4.2. Market Revenue (US$Mn) and Volume (Units) Forecast, By Distribution Channel
4.2.1. Hospitals
4.2.2. Ambulatory Surgical Centers
4.2.3. Obstructive And Gynaecology Clinics
4.2.4. Government And Non-Profit Organizations
4.3. Global Intrauterine Devices Attractiveness Index, By Distribution Channel
5. Global Intrauterine Devices, By Region
5.1. Introduction
5.1.1. Annual Growth Rate Comparison, By Region
5.1.2. BPS Analysis, By Region
5.2. Market Revenue (US$Mn) and Volume (Units) Forecast, By Region
5.2.1. North America
5.2.2. Latin America
5.2.3. Europe
5.2.4. Asia Pacific
5.2.5. Middle East and Africa
5.3. Global Intrauterine Devices Attractiveness Index, By Region
6. North America Intrauterine Devices Analysis and Forecast, 2019–2027
6.1. Introduction
6.1.1. Annual Growth Rate Comparison, By Country
6.1.2. BPS Analysis, By Country
6.2. Market Revenue (US$Mn) and Volume (Units) Forecast, By Country
6.2.1. U.S. Intrauterine Devices
6.2.2. Canada Intrauterine Devices
6.3. North America Intrauterine Devices, By Devices
6.3.1. Copper Devices (Inert Iuds)
6.3.2. Hormonal Devices
6.4. North America Intrauterine Devices, By Distribution Channel
6.4.1. Hospitals
6.4.2. Ambulatory Surgical Centers
6.4.3. Obstructive And Gynaecology Clinics
6.4.4. Government And Non-Profit Organizations
6.5. North America Intrauterine Devices Attractiveness Index
6.5.1. By Country
6.5.2. By Devices
6.5.3. By Distribution Channel
7. Latin America Intrauterine Devices Analysis and Forecast, 2020–2028
7.1. Introduction
7.1.1. Annual Growth Rate Comparison, By Country
7.1.2. BPS Analysis, By Country
7.2. Market (US$Mn) and Volume (Units) Forecast, By Country
7.2.1. Brazil Intrauterine Devices
7.2.2. Mexico Intrauterine Devices
7.2.3. Argentina Intrauterine Devices
7.2.4. Rest of Latin America Intrauterine Devices
7.3. Latin America Intrauterine Devices, By Devices
7.3.1. Copper Devices (Inert Iuds)
7.3.2. Hormonal Devices
7.4. Latin America Intrauterine Devices, By Distribution Channel
7.4.1. Hospitals
7.4.2. Ambulatory Surgical Centers
7.4.3. Obstructive And Gynaecology Clinics
7.4.4. Government And Non-Profit Organizations
7.5. Latin America Intrauterine Devices Attractiveness Index
7.5.1. By Country
7.5.2. By Devices
7.5.3. By Distribution Channel
8. Europe Intrauterine Devices Analysis and Forecast, 2020–2028
8.1. Introduction
8.1.1. Annual Growth Rate Comparison, By Country
8.1.2. BPS Analysis, By Country
8.2. Market (US$Mn) and Volume (Units) Forecast, By Country
8.2.1. U.K. Intrauterine Devices
8.2.2. Germany Intrauterine Devices
8.2.3. Italy Intrauterine Devices
8.2.4. France Intrauterine Devices
8.2.5. Spain Intrauterine Devices
8.2.6. Russia Intrauterine Devices
8.2.7. Poland Intrauterine Devices
8.2.8. BENELUX Intrauterine Devices
8.2.9. NORDIC Intrauterine Devices
8.2.10. Rest of Europe Intrauterine Devices
8.3. Europe Intrauterine Devices, By Devices
8.3.1. Copper Devices (Inert Iuds)
8.3.2. Hormonal Devices
8.4. Europe Intrauterine Devices, By Distribution Channel
8.4.1. Hospitals
8.4.2. Ambulatory Surgical Centers
8.4.3. Obstructive And Gynaecology Clinics
8.4.4. Government And Non-Profit Organizations
8.5. Europe Intrauterine Devices Attractiveness Index
8.5.1. By Country
8.5.2. By Devices
8.5.3. By Distribution Channel
9. Asia Pacific Intrauterine Devices Analysis and Forecast, 2020–2028
9.1. Introduction
9.1.1. Annual Growth Rate Comparison, By Country
9.1.2. BPS Analysis, By Country
9.2. Market (US$Mn) and Volume (Units) Forecast, By Country
9.2.1. China Intrauterine Devices
9.2.2. India Intrauterine Devices
9.2.3. Japan Intrauterine Devices
9.2.4. Australia and New Zealand Intrauterine Devices
9.2.5. South Korea Intrauterine Devices
9.2.6. ASEAN Intrauterine Devices
9.2.7. Rest of Asia Pacific Intrauterine Devices
9.3. Asia Pacific Intrauterine Devices, By Devices
9.3.1. Copper Devices (Inert Iuds)
9.3.2. Hormonal Devices
9.4. Asia Pacific Intrauterine Devices, By Distribution Channel
9.4.1. Hospitals
9.4.2. Ambulatory Surgical Centers
9.4.3. Obstructive And Gynaecology Clinics
9.4.4. Government And Non-Profit Organizations
9.5. Asia Pacific Intrauterine Devices Attractiveness Index
9.5.1. By Country
9.5.2. By Devices
9.5.3. By Distribution Channel
10. Middle East Intrauterine Devices, By Region
10.1. Introduction
10.1.1. Annual Growth Rate Comparison, By Country
10.1.2. BPS Analysis, By Country
10.2. Market (US$Mn) and Volume (Units) Forecast, By Country
10.2.1. GCC Countries Intrauterine Devices
10.2.2. Israel Intrauterine Devices
10.2.3. Oman Intrauterine Devices
10.2.4. Rest of Middle East Intrauterine Devices
10.3. Middle East Intrauterine Devices, By Devices
10.3.1. Copper Devices (Inert Iuds)
10.3.2. Hormonal Devices
10.4. Middle East Intrauterine Devices, By Distribution Channel
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Obstructive And Gynaecology Clinics
10.4.4. Government And Non-Profit Organizations
10.5. Middle East Intrauterine Devices Attractiveness Index
10.5.1. By Country
10.5.2. By Devices
10.5.3. By Distribution Channel
11. Africa Intrauterine Devices, By Region
11.1. Introduction
11.1.1. Annual Growth Rate Comparison, By Country
11.1.2. BPS Analysis, By Country
11.2. Market (US$Mn) and Volume (Units) Forecast, By Country
11.2.1. South Africa Intrauterine Devices
11.2.2. Egypt Intrauterine Devices
11.2.3. North Africa Intrauterine Devices
11.2.4. Rest of Africa Intrauterine Devices
11.3. Africa Intrauterine Devices, By Devices
11.3.1. Copper Devices (Inert Iuds)
11.3.2. Hormonal Devices
11.4. Africa Intrauterine Devices, By Distribution Channel
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Obstructive And Gynaecology Clinics
11.4.4. Government And Non-Profit Organizations
11.5. Africa Intrauterine Devices Attractiveness Index
11.5.1. By Country
11.5.2. By Devices
11.5.3. By Distribution Channel
12. Recommendation
12.1. Market Strategy
13. Competitive Landscape
13.1. Competition Dashboard
13.2. List and Company Overview of Global Key Players
13.3. Company Profiles
13.3.1. Pfizer Inc.
13.3.1.1. Company Overview
13.3.1.2. Financial Overview
13.3.1.3. Product Portfolio
13.3.1.4. Key Developments
13.3.1.5. Business Strategies
13.3.2. Agile Therapeutics
13.3.3. Allergan Inc.
13.3.4. Bayer AG
13.3.5. Teva Pharmaceutical Company Limited
13.3.6. Besins HealthCare
13.3.7. Brecuro Medical
13.3.8. Effik International
13.3.9. Eurogine
13.3.10. HLL Lifecare
13.3.11. HRA Pharma
13.3.12. Medisafe Distribution
13.3.13. OCON Medical
13.3.14. Pregna
13.3.15. SMB
14. Acronyms
Frequently Asked Questions
What is the projected market size & Compound Annual Growth Rate (CAGR) of the market?
The global intrauterine devices market in 2020 is estimated for more than US$ 4.1 Bn and expected to reach a value of US$ 5.9 Bn by 2028 with a significant CAGR of 4.5%.
What are the key factors driving the growth of market?
Intrauterine devices are quickly gaining attention due to the growing incidence of unintended pregnancies and sexually transmitted diseases it helps to control huge healthcare expenditure on abortions and other health complications of STDs
What segments are covered in market report?
The global intrauterine devices market is segmented on the basis of product type, distribution channel, and region
What are the key participating players in the market?
The global intrauterine devices market is highly consolidated and is mainly dominated by Pfizer Inc., Agile Therapeutics, Allergan Inc., Bayer AG, Teva Pharmaceutical Company Limited, etc.
